U.S. Oil and Gas Stock News

Plains All American Pipeline stock has delivered a very large 255.7% return over the past 5 years, yet its current valuation checks and market multiples now point to a picture that looks closer to fairly priced than clearly cheap. A 255.7% 5 year return puts Plains All American Pipeline among the stronger long term performers in its peer group, which naturally raises the bar for what counts as good value today. For valuation, the key support comes from how reliably the business can turn its...

Ondas (ONDS) is back in focus after securing US$70 million in new defense and autonomous technology orders and unveiling its Ondas Sentinel defense division, which is sharpening attention on how these contracts might shape the stock. See our latest analysis for Ondas. Ondas has seen mixed momentum around the latest defense orders, with the 7 day share price return up 19.25% even as the 30 day and year to date share price returns are down. At the same time, the 1 year total shareholder return...

Gen Digital (GEN) is in focus after recent share movements left the cyber safety company showing mixed return patterns, with gains over the past month alongside share price declines over the past year. See our latest analysis for Gen Digital. At the latest share price of US$25.07, Gen Digital shows fading short term momentum, with a 1 day share price return of 1.99% and a 7 day share price return of 7.18% down. This sits against a stronger 90 day share price return of 31.67% and a 3 year...

NNN REIT has delivered a 32.1% total return over the past three years, yet valuation checks that include an intrinsic value estimate using a Discounted Cash Flow (DCF) model still point to the shares trading at a discount to that estimate and to market multiples that screen as cheap. A 32.1% total return over three years suggests NNN REIT has already rewarded patient shareholders, raising the question of how much upside may be left if the discount to intrinsic value closes. The 37th...

F5 (FFIV) recently expanded its F5 Insight for ADSP platform with new fleet management tools for BIG-IP environments, aiming to tighten security workflows as frontier AI shortens the window between new vulnerabilities and exploitation. See our latest analysis for F5. F5’s share price has eased in the past week and month, but a 90 day share price return of 28.01% and a year to date gain of 51.22% indicate that momentum has been strong, supported by recent AI focused product updates and...

Joby Aviation (JOBY) drew fresh attention after finalizing a multi year commercial agreement with Virgin Atlantic, making the airline its exclusive UK partner and integrating Joby’s electric air taxi service at London Heathrow and Manchester. See our latest analysis for Joby Aviation. Despite the Virgin Atlantic agreement and recent showings at Farnborough and other events, Joby Aviation’s 1 year total shareholder return is down 56.94%, while the year to date share price return has fallen...

Strategy, listed as NasdaqGS:MSTR, has joined the new Bitcoin Security Consortium alongside BlackRock, Coinbase and other major institutions. The company has pledged $15m to support efforts to make Bitcoin security more resilient to potential quantum computing threats. This consortium marks a coordinated industry effort to address long term Bitcoin security risks beyond short term market moves. For investors tracking Strategy at a share price of $93.63, the decision to back the Bitcoin...

Penske Automotive Group stock has delivered a strong 179.4% return over the past 5 years, yet its broader valuation checks lean more expensive and sit alongside a take private proposal at a price below the current market level. Together, these factors make the current share price harder to read. Over the last 5 years, Penske Automotive Group has returned 179.4%, which puts recent gains in context and raises the bar for what would justify further upside. The proposed US$210 per share take...

BioMarin Pharmaceutical (BMRN) stock is back in focus after the FDA accepted the company’s supplemental New Drug Application for VOXZOGO, a key regulatory step toward potential full approval in achondroplasia. See our latest analysis for BioMarin Pharmaceutical. At a share price of US$58.87, BioMarin Pharmaceutical has seen a 10.7% 90 day share price return, while the 1 year total shareholder return has declined 1.5%, suggesting recent momentum contrasts with weaker longer term results. If...

In the past quarter, Vicor Corporation reported second-quarter 2026 revenue of US$143.35 million and net income of US$49.77 million, with both basic and diluted earnings per share from continuing operations rising year-on-year and first-half 2026 results also showing higher revenue and earnings versus the prior year. Beyond the headline figures, Vicor’s results were supported by strong demand for advanced power products tied to AI infrastructure, growing licensing income, and management’s...

First Citizens BancShares, Inc. reported past second-quarter 2026 results showing net interest income of US$1,656 million and net income of US$672 million, with basic and diluted EPS from continuing operations of US$55.52, alongside affirming a quarterly dividend of US$2.10 per share payable in September 2026. Alongside higher earnings, the company completed a large US$2.69 billion buyback program that retired 11.23% of its shares, signaling strong capital flexibility and management...

SiTime’s share price has delivered very strong gains over the past three years, yet the valuation checks now lean expensive, which raises the question of how much optimism is already reflected in the current US$576.41 level. The stock has returned 376.1% over three years, which puts extra focus on whether the current price already embeds a lot of the expected growth story. The recently completed acquisition of Renesas' timing business can support growth expectations in precision timing and...

Intel (NasdaqGS:INTC) has signed a non binding memorandum of understanding with Lens Technology focused on advanced TGV packaging. The agreement targets collaboration across AI PC hardware, data center platforms, and edge robotics devices. The arrangement signals potential cross border cooperation in precision manufacturing for next generation semiconductor packaging. Intel enters this announcement with its shares at $100.23 and very large 1 year and multi year returns, including a 196.0%...

Stifel Financial (SF) is back in focus after reporting Q2 2026 results and updating investors on its long running share repurchase program, giving shareholders fresh numbers on profitability and capital returns. See our latest analysis for Stifel Financial. Stifel Financial's recent earnings surprise and long running buyback program come after a mixed share price stretch, with a 1 month share price return of 8.16% contrasting with a year to date decline of 6.99%, while the 3 year total...

Earlier this week, Neurocrine Biosciences announced a series of leadership moves, including appointing Samir Siddhanti as Chief Business Officer and naming three new Senior Vice Presidents across market access, intellectual property, and finance. Together, these appointments signal a concerted push to reinforce commercial execution, protect the company’s neuroscience portfolio, and sharpen capital and business development decisions as it matures into a broader multi-product biopharma...

Encore Capital Group (ECPG) told investors it will redeem all outstanding 4.00% Convertible Senior Notes due 2029, covering $230.0 million in principal, with redemption scheduled for September 24, 2026. See our latest analysis for Encore Capital Group. The recent weakness in Encore Capital Group’s share price, with the stock down 7.25% on a 7 day share price return despite a 53.16% year to date share price return and a 120.87% 1 year total shareholder return, suggests strong longer term...

Nektar Therapeutics recently initiated the first two global registrational Phase 3 trials, ZENITH AD-1 and ZENITH AD-2, for rezpegaldesleukin in patients aged 12 and older with moderate-to-severe atopic dermatitis, following encouraging Phase 2b data and prior FDA Fast Track designations. This move advances a first-in-class T-reg–targeting biologic into pivotal testing across North America, Europe and Asia-Pacific, underscoring Nektar’s ambition to build a broad autoimmune and inflammatory...

Wendy's stock has had a weak stretch over the past few years, yet the current valuation work suggests the shares may now be trading at a discount, with both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings-based multiples pointing in the same direction. Wendy's shareholders have seen the stock decline 60.8% over the past 5 years, which sets expectations low and makes the current pricing especially important to scrutinize. For a consumer-focused restaurant chain, the key...

Zillow Group (ZG) is back in focus after fresh housing data tied the company to two pressure points in the U.S. market: rising asking rents and efforts to ease the housing deficit. See our latest analysis for Zillow Group. Against this backdrop, Zillow Group’s share price has come under pressure, with the stock down 5.71% over the past day and 35.22% over 90 days, while the 1 year total shareholder return has declined 61.78%. This suggests sentiment has weakened despite its role in current...

JPMorgan Chase is among global banks arranging a record $40 billion bridge loan for SoftBank to support its artificial intelligence investments. The financing is tied to SoftBank's broader push into AI, including potential opportunities around an anticipated OpenAI IPO. The transaction ranks as one of Asia's largest loan deals and highlights strong bank appetite for large scale technology related funding. For investors watching NYSE:JPM, this SoftBank deal puts JPMorgan Chase at the center...

Agilysys (AGYS) is drawing attention after recent share price moves, with the stock down 2.1% over the past day but up about 10% over the past month and 42% in the past 3 months. See our latest analysis for Agilysys. At a share price of $95.01, Agilysys has recently given investors a mixed ride, with short term share price weakness over the past week but strong 3 month momentum and a positive 3 year total shareholder return of 33.48%. If Agilysys’s recent swings have you thinking about where...

Earlier this month, Belden Inc. announced that its CloudRail brand has partnered with Tulip to help life sciences and consumer packaged goods manufacturers digitize brownfield operations by securely connecting legacy equipment to modern frontline applications without disrupting production. The collaboration marries Belden’s vendor-agnostic OT data acquisition and contextualization with Tulip’s frontline operations platform, aiming to unlock trapped production data and quickly improve overall...

Axon Enterprise stock sits at an unusual valuation crossroads, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium to the current share price while market based multiples suggest the stock screens as undervalued. Axon Enterprise has returned 170.1% over the past 3 years, which puts more pressure on today’s price to justify expectations built into that run. Expectations for bookings growth, including from areas highlighted in recent brokerage commentary such as...

NETSTREIT Corp. has already reported its second-quarter 2026 results, with sales rising to US$57.82 million and revenue reaching US$61.28 million, alongside net income of US$6.29 million and basic earnings per share from continuing operations of US$0.06. For the first half of 2026, NETSTREIT more than doubled net income to US$11.97 million while also lifting the quarterly dividend to US$0.2250 per share, underscoring a focus on income distribution as cash flows improved. Now we will...